Synergy CHC Corp (SNYR) 2025 Q2 法說會逐字稿

Good morning, everyone, and thank you for participating in today's conference call to discuss Synergy CHC Corporation's financial results for the second quarter ended June 30, 2025. Joining us today are Synergy's CEO, Jack Ross; CFO, Jaime Fickett; and Greg Robles with Investor Relations. Following their remarks, we'll open the call for analyst questions.

Before we go further, I would like to turn the call over to Mr. Robles as he reads the company's Safe Harbor statement. Greg, please go ahead.

Thanks, Lisa. Good morning, and thanks for joining our conference call to discuss our second-quarter 2025 financial results. I'd like to remind everyone that this call is available for replay and via a live webcast that will be posted on our Investor Relations website at investors.synergychc.com.

The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's SEC filings under the caption Risk Factors. Information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein.

Now, I would like to turn the call over to the CEO of Synergy, Jack Ross. Jack?

Thank you, Greg. Good morning, everyone. Thank you for joining us today to discuss Synergy's performance for the second quarter of 2025.

We are very pleased to report that the quarter marked our 10th consecutive quarter of profitability, a significant milestone that reflects our continued operational discipline and focused execution. Revenue, gross profit, net income, earnings per share all grew year over year, underscoring the strength of our platform as we continue scaling profitability.

Before we get into the results, let me touch on a few key developments across our business. First, an update on our international expansion. Following last quarter's announcement of a license agreement for the UAE, we have expanded that agreement to now include Turkey, further extending our global footprint for the FOCUSfactor brand. These agreements allow us to enter high potential international markets in a capital-efficient way, and we expect both regions to begin generating additional revenue before the end of this year.

We continue to pursue additional licensing partnerships in markets where we do not intend to establish a direct footprint. We have completed a formation of a new wholly owned subsidiary in Mexico. We are actively engaging manufacturing partners and customers. We expect to be shipping our first two new customers, Costco Mexico and Walmart Mexico, late in the third quarter or early in the fourth quarter of fiscal 2025. We still plan on entering Australia and Taiwan markets early in the fourth quarter of fiscal 2025, with Costco being the lead customer in both regions.

Next, I would like to update you on the functional beverage business momentum that continues to build both operationally and organizationally. During the second quarter, we have assembled a high-caliber leadership team to drive Synergy's beverage strategy and growth. Their decades of collective experience across CPG, convenience, and global retail development will position us to scale quickly and effectively.

In fact, the growth is already translating the shelf. During the second quarter, we secured some of the most significant distribution wins in Synergy's history, which will meaningfully expand access to both FOCUSfactor supplements and Focus + Energy beverages across North America.

A few highlights on the beverage side, Core-Mark, a division of Performance Food Group, one of North America's largest food and beverage distributors, granted national item authorization for FOCUSfactor Focus + Energy, unlocking access to sell to over 50,000 retail locations across the US and Canada. On the supplement side, Walmart Canada will be launching two SKUs nationally in Q4, marking a major milestone for us. This placement builds on our 18-year relationship with Walmart US and further affirms FOCUSfactor's leadership in growing the brain health category.

In parallel, McKesson Canada, the country's largest pharmaceutical distributors, has signed a national distribution agreement that gives us access to thousands of pharmacies and wellness retailers across Canada. These retail wins are a clear signal that our expanding reach and growing relevance with both consumers and retail partners, combined with strong execution from our leadership team, we expect the momentum to accelerate into the second half and beyond.

Before passing the call over to Jaime, our CFO, I want to touch briefly on our debt refinancing, which we announced we completed in June. We entered into a new $20 million term loan credit facility, of which we've drawn down $17.5 million of that facility to pay out previous facilities. This extends our debt maturity date into 2029, which includes interest-only payments through the end of '25.

The transaction immediately improves our balance sheet by eliminating all short-term debt obligations and providing growth capital to support our strategic initiatives. We view this refinancing as a major milestone that enhances financial flexibility, increases free cash flow in the near term, and better aligns our capital structure with Synergy's long-term growth strategy.

With those updates, I'd like to turn the call over to our Chief Financial Officer, Jaime Fickett. Jaime?

Thank you, Jack. I'll now review our financial results.

For the second quarter of 2025, net revenue was $8.1 million, compared to $8 million in the year-ago quarter, reflecting an increase of 1%. We also generated $1.4 million in license fee revenue during the quarter. Gross margin for the second quarter was 76.7%, compared to 69.5% in the same quarter last year. The increase in gross margin was primarily driven by license revenue.

Operating expenses for the second quarter were $4.6 million, compared to $4 million in the year-ago quarter. The increase in operating expenses was primarily due to the incremental costs associated with being a public company.

Income from operations was $1.62 million, up 2.5% from $1.58 million, compared to the second quarter of 2024. Net income for the second quarter was $1.47 million, compared to $655,000 in the year-ago quarter, representing an increase of 125%.

Earnings per share for the second quarter was $0.17 per diluted share, compared to $0.09 per diluted share in the year-ago quarter, representing an increase of 86%. These increases reflect the successful execution of our strategic growth initiatives and cost management.

EBITDA for the second quarter was $3.8 million, up 136%, compared to $1.61 million in the second quarter of 2024.

Moving to our balance sheet, as of June 30, 2025, we had cash and cash equivalents of $1.5 million, compared to $687,900 as of December 31, 2024. Inventory was $2.4 million at the end of the second quarter, compared to $1.7 million at December 31, 2024.

At June 30, 2025, we had $32.1 million in total liabilities, which compares to $33 million in total liabilities at December 31, 2024, which is a decrease of $869,000 in the second quarter. Subsequent to the quarter-end, we have also reduced our outstanding notes payable by an additional $1.8 million.

At June 30, 2025, we had a working capital surplus of $12.4 million, compared to a working capital deficit of $1.12 million as of December 31, 2024.

For the six months ended June 30, 2025, our cash used in operating activities was $899,700, compared to cash used in operating activities of $1.1 million at June 30, 2024. The decrease primarily reflects higher net income, partially offset by changes in working capital, including increases in accounts receivable and inventory.

Now, I will turn the call back to the operator.

(Operator Instructions) Sean McGowan, Roth Capital Partners.

Hi. Good morning, Jack. Good morning, Jaime. How are you?

Good morning, Sean. How are you today?

Good. A couple of questions on the RTD. So were you able to book much revenue in the quarter? Or is that still to come?

Mostly still to come, but we did see a significant improvement on our Amazon sell-through relatively speaking. Quarter over quarter, last quarter, I think we sold $41,000 on Amazon. This quarter, it was three times that. It was $148,000, if you will.

So as you know, the minute that we closed our financing round, our debt restructuring, and we could utilize the capital to start growing our RTD business in a meaningful way, we instantly switched and started adding team and started signing retail partners. So more to come on RTDs very quickly in the third and fourth quarter.

Okay. So besides Amazon, what retailers currently have the product on shelf like right now?

Multiple retailers in Canada. I'd have to get you a list of them, Sean, but multiple retailers in Canada, if you will.

You've asked a bunch of those. I'm just wondering, have we started to see that revenue? Or is that not yet showing up? I'm trying to get a sense of how much was it in the quarter.

$148,000 in the quarter.

Okay. Thank you on that. And I assume that the licensing revenue is basically 100% gross margin?

Correct.

Would you expect the licensing revenue to -- I'm not sure how the deals are constructed. Is it strictly a percentage of sales? Or do you get kind of steady payments? What should we expect that line to do? Is that going to grow slowly, or is it going to be lumpy?

Yeah. So it's going to grow slowly. We are talking to other groups in other countries. Again, we only plan to do those deals where we don't intend to put a sales team or our own organization to sell the retail. So we are talking to some other groups, but we don't really expect anything in the third quarter for licensing revenue. So it might be a little bumpy, if you will.

Okay. Got it. So Jaime, could you talk about any expenses that hit the quarter that you would say are kind of unusual or non-recurring? Is there anything of that nature?

We did have a lot of professional fees and legal expenses that were higher than normal, again, due to being a public market company. Selling and operations was in line. I would say that would be the only one-timers or unusual in the quarter.

Okay. But those professional fees, I mean, the cost of being public are going to persist, right?

Yeah, correct. But they didn't index against last year. That's all she's saying.

Right. All right. And then Mexico, will that be accounted for as a revenue or a license deal? That's revenue, right?

That's revenue. We have our own footprint there. We have our own company there. Really, anywhere Costco is, we'll have our own sales teams and have our own revenue, if you will.

Okay. And were you able to book any Flat Tummy revenue in this quarter?

Flat Tummy is staying pretty steady, but we'll call nothing new to report at this point in time.

All right. Thank you very much.

Okay. Thank you, Sean.

Thank you. And this does conclude today's Q&A session, and I would like to go ahead and turn the call back over to Mr. Ross for closing remarks. Please go ahead.

Thank you, Lisa. We'd like to thank everyone for joining the earnings call today, and we look forward to speaking with you when we report the third-quarter results in the middle of November. Thank you.

Ladies and gentlemen, this does conclude today's teleconference. You may disconnect your lines at this time. Thank you for your participation.